F. Trinkmann (Heidelberg, Germany)
Late Breaking Abstract - Management of asthma in pregnancy using fractional exhaled nitric oxide (FENO) to adjust inhaled corticosteroid (ICS) dose did not improve perinatal outcomes: the Breathing for Life Trial (BLT)
V. Murphy (Callaghan, Australia), M. Jensen (Callaghan, Australia), E. Holliday (Callaghan, Australia), W. Giles (Sydney, Australia), H. Barrett (Brisbane, Australia), L. Callaway (Brisbane, Australia), A. Bisits (Sydney, Australia), M. Peek (Canberra, Australia), S. Seeho (Sydney, Australia), A. Abbott (Sydney, Australia), P. Colditz (Brisbane, Australia), A. Searles (Newcastle, Australia), J. Attia (Newcastle, Australia), M. Hensley (Newcastle, Australia), J. Mattes (Newcastle, Australia), P. Gibson (Newcastle, Australia)
|   |
Late Breaking Abstract - Small Airways Dysfunction (SAD) correlates with relevant asthma outcomes: longitudinal results from the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study
M. Kraft (Tucson, United States of America), G. Nicolini (Parma (PR), Italy), M. Van Den Berge (Groningen, Netherlands), C. Brightling (Leicester, United Kingdom), L. Fabbri (Ferrara, Italy), T. Van Der Molen (Groningen, Netherlands), A. Papi (Ferrara, Italy), K. Rabe (Kiel, Germany), S. Siddiqui (Leicester, United Kingdom), D. Singh (Manchester, United Kingdom), D. Postma (Groningen, Netherlands)
| |
Within-day repeatability of fractional exhaled nitric oxide in severe asthma
R. Wang (Manchester (Greater Manchester), United Kingdom), F. Alahmadi (Manchester (Greater Manchester), United Kingdom), R. Niven (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom)
| |
Real life spirometry analysis according to age groups.
A. REZOLA CARASUSAN (Barakaldo, Spain), A. Gomez Larrauri (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), L. Lorea Martinez Indart (Barakaldo, Spain), J. Benavent Benavent Marco (Barcelona, Spain), E. Tabernero Huguet (Barakaldo, Spain), N. Marina Malanda (Barakaldo, Spain)
| |
Changes in exhaled breath particles lipid composition following experimental endotoxin challenge
O. Holz (Hannover, Germany), P. Larsson (Gothenburg , Sweden), H. Biller (Hannover, Germany), G. Koster (Southampton, United Kingdom), A. Postle (Southampton, United Kingdom), A. Olin (Gothenburg , Sweden), J. Hohlfeld (Hannover, Germany)
| |
Transdiaphragmatic pressure in COPD patient and its correlation with diaphragm dynamics including spirometry findings.
S. Agarwal (new delhi, India), R. Guleria (new delhi, India), A. Mohan (new delhi delhi, India), K. Madan (new delhi, India), G. Khilnani (new delhi, India), V. Hadda (new delhi, India), G. Chawla (new delhi, India)
| |
The relationship of spirometric and echocardiographic (ECHO) parameters in children with bronchial asthma (BA)
N. POPOVA (Moscow, Russian Federation), . Nikitina (Moscow, Russian Federation), . Egorskaya (Nizhny Novgorod , Russian Federation), L. Egorskaya (Nizhny Novgorod , Russian Federation), . Prahov (Nizhny Novgorod , Russian Federation), O. Vinogradova (Nizhny Novgorod , Russian Federation), S. Soodaeva (Moscow, Russian Federation), I. Klimanov (Moscow, Russian Federation), . Glukhova (Moscow, Russian Federation)
| |
Decreased lung function is associated with vitamin D deficiency in middle aged Korean health screening examinee
H. Park (Goyang-Si, Republic of Korea), H. Jun (Seoul, Republic of Korea), J. Lee (Jeju, Republic of Korea), J. Song (Seoul, Republic of Korea)
| |
Feasibility of home spirometry in patients with chronic graft-versus-host disease: a prospective observational study
J. Turner (Hamilton, Canada), C. He (Seattle, United States of America), L. Chung (Seattle, United States of America), K. Baker (Seattle, United States of America), J. Hubbard (Seattle, United States of America), E. Rankin (Seattle, United States of America), M. Guerriero (Seattle, United States of America), M. Boeckh (Seattle, United States of America), K. Syrjala (Seattle, United States of America), P. Martin (Seattle, United States of America), T. Gooley (Seattle, United States of America), S. Lee (Seattle, United States of America), M. Flowers (Seattle, United States of America), G. Cheng (Seattle, United States of America)
| |
Reference values for lung clearance index (LCI) derived from sulphur hexafluoride multiple breath washout testing.
F. Trinkmann (Heidelberg, Germany), M. Maros (Mannheim, Germany), K. Roth (Mannheim, Germany), A. Hermanns (Mannheim, Germany), J. Schäfer (Mannheim, Germany), J. Gawlitza (Mannheim, Germany), J. Saur (Mannheim, Germany), I. Akin (Mannheim, Germany), M. Borggrefe (Mannheim, Germany), T. Ganslandt (Mannheim, Germany), F. Herth (Heidelberg, Germany)
| |
Pulmonary dysfunction after treatment for childhood cancer – Comparing multiple-breath washout with spirometry
J. Usemann (Basel, Switzerland), C. Schindera (Basel, Switzerland), S. Zuercher (Basel, Switzerland), R. Jung (Basel, Switzerland), R. Kasteler (Bern, Switzerland), B. Frauchiger (Bern, Switzerland), C. Rueegg (Oslo, Norway), P. Latzin (Oslo, Norway), C. Kuehni (Bern, Switzerland), N. Von Der Weid (Basel, Switzerland)
| |
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
K. Ansarin (Tabriz, Islamic Republic of Iran), E. Seiyedrezazadeh (Tabriz, Islamic Republic of Iran)
| |
Predicting survival in COPD using the transfer factor for carbon monoxide Z-score
R. Pel (Enschede, Netherlands), T. Fabius (Enschede, Netherlands), E. Citgez (Enschede, Netherlands), F. De Jongh (Enschede, Netherlands), M. Brusse-Keizer (Enschede, Netherlands)
| |
Relationship of cardiac biomarkers in COPD to exacerbation and hyperinflation
M. Macleod (London, United Kingdom), G. Donaldson (London, United Kingdom), J. Allinson (London, United Kingdom), D. Wiseman (London, United Kingdom), J. Wedzicha (London, United Kingdom)
| |
The prognostic value of extended lung function characterization in COPD
T. Pincikova (Uppsala, Sweden), J. Ellingsen (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), H. Hedenström (Uppsala, Sweden), K. Bröms (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), M. Högman (Uppsala, Sweden), C. Janson (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Higher levels of alveolar nitric oxide in asthmatic frequent exacerbation: a pilot study.
F. Bertolini (Orbassano, Italy), R. Fucà (Orbassano, Italy), E. Riccardi (Orbassano, Italy), V. Carriero (Orbassano, Italy), A. Sprio (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
| |
Normal range for bronchodilation response in impulse oscillometry parameters in healthy adults
H. Johansson (Uppsala, Sweden), C. Janson (Uppsala, Sweden), X. Zhou (Uppsala, Sweden), J. Sundström (Uppsala, Sweden), P. Wollmer (Lund, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Prediction of peak expiratory flow of the next day through a smartphone application designed for individuals with asthma
P. Sakkatos (London, United Kingdom), T. Antalffy (London, United Kingdom), N. Pavlovskaia (London, United Kingdom)
| |
A systematic review of the use of physiological tests assessing the acute response to treatment during exacerbations of COPD
N. Alobaidi (Birmingham , United Kingdom), M. Almeshari (Birmingham , United Kingdom), J. Stockley (Birmingham , United Kingdom), E. Sapey (Birmingham , United Kingdom), R. Edgar (Birmingham , United Kingdom)
| |
Activation of the cascade-system in small airways- a pilot study in asthma with small airway involvement
A. Olin (Gothenburg, Sweden), S. Kokelj (Gothenburg, Sweden), J. Östling (Gothenburg, Sweden)
| |